Deschloroetizolam
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Dependence liability |
Moderate |
| Routes of administration |
Oral, sublingual, rectal |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C17H16N4S |
| Molar mass | 308.40 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Deschloroetizolam (also known as Etizolam-2) is a thienotriazolodiazepine that is the dechlorinated analog of the closely related etizolam. The compound has been sold as a designer drug.
Legal status
Deschloroetizolam is classified and controlled as a hazardous substance in Sweden as of on October 15, 2015.
See also
- Adinazolam
- Clonazolam
- Deschloroclotizolam
- Diclazepam
- Etizolam
- Flubromazepam
- Flubromazolam
- Fluetizolam
- Meclonazepam
- Metizolam
- Nifoxipam
- Pyrazolam
| 5-HT1AR agonists | |
|---|---|
| GABAAR PAMs |
|
|
Gabapentinoids |
|
| Antidepressants |
|
|
Sympatholytics |
|
| Others | |
| |
| PAFR |
|
||||
|---|---|---|---|---|---|
| Others |
|
||||
| |||||